Skip Nav Destination
Letter to Blood|
October 5, 2023
Chemotherapy-induced reversal of ciltacabtagene autoleucel–associated movement and neurocognitive toxicity
Clinical Trials & Observations
Charlotte E. Graham,
Charlotte E. Graham
1Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA
2Department of Medicine, Harvard Medical School, Boston, MA
3Department of Pathology, Harvard Medical School, Boston, MA
Search for other works by this author on:
Won-Ho Lee,
Won-Ho Lee
1Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA
Search for other works by this author on:
Hadley R. Wiggin,
Hadley R. Wiggin
1Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA
Search for other works by this author on:
Valentina M. Supper,
Valentina M. Supper
1Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA
Search for other works by this author on:
Mark B. Leick,
Mark B. Leick
1Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA
2Department of Medicine, Harvard Medical School, Boston, MA
3Department of Pathology, Harvard Medical School, Boston, MA
Search for other works by this author on:
Filippo Birocchi,
Filippo Birocchi
1Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA
2Department of Medicine, Harvard Medical School, Boston, MA
3Department of Pathology, Harvard Medical School, Boston, MA
Search for other works by this author on:
Andrew J. Yee,
Andrew J. Yee
2Department of Medicine, Harvard Medical School, Boston, MA
3Department of Pathology, Harvard Medical School, Boston, MA
4Center for Multiple Myeloma, Massachusetts General Hospital, Boston, MA
Search for other works by this author on:
Angelina Petrichenko,
Angelina Petrichenko
5Department of Microbiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
Search for other works by this author on:
John Everett,
John Everett
5Department of Microbiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
Search for other works by this author on:
Frederic D. Bushman,
Frederic D. Bushman
5Department of Microbiology, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA
Search for other works by this author on:
Hossein Sadrzadeh,
Hossein Sadrzadeh
1Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA
Search for other works by this author on:
Otto Rapalino,
Otto Rapalino
2Department of Medicine, Harvard Medical School, Boston, MA
3Department of Pathology, Harvard Medical School, Boston, MA
6Department of Radiology, Massachusetts General Hospital, Boston, MA
Search for other works by this author on:
Daniel Chiu,
Daniel Chiu
2Department of Medicine, Harvard Medical School, Boston, MA
3Department of Pathology, Harvard Medical School, Boston, MA
7Department of Neurology, Massachusetts General Hospital, Boston, MA
Search for other works by this author on:
Isabel Arrillaga-Romany,
Isabel Arrillaga-Romany
2Department of Medicine, Harvard Medical School, Boston, MA
3Department of Pathology, Harvard Medical School, Boston, MA
7Department of Neurology, Massachusetts General Hospital, Boston, MA
Search for other works by this author on:
Marcela V. Maus,
Marcela V. Maus
1Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA
2Department of Medicine, Harvard Medical School, Boston, MA
3Department of Pathology, Harvard Medical School, Boston, MA
Search for other works by this author on:
Matthew J. Frigault,
Matthew J. Frigault
1Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA
2Department of Medicine, Harvard Medical School, Boston, MA
3Department of Pathology, Harvard Medical School, Boston, MA
Search for other works by this author on:
Kathleen M. E. Gallagher
Kathleen M. E. Gallagher
1Cellular Immunotherapy Program, Cancer Center, Massachusetts General Hospital, Boston, MA
2Department of Medicine, Harvard Medical School, Boston, MA
3Department of Pathology, Harvard Medical School, Boston, MA
Search for other works by this author on:
Blood (2023) 142 (14): 1248–1252.
Article history
Submitted:
June 7, 2023
Accepted:
July 11, 2023
First Edition:
July 19, 2023
Connected Content
A commentary has been published:
BCMA-CAR T-cell treatment–associated parkinsonism
Citation
Charlotte E. Graham, Won-Ho Lee, Hadley R. Wiggin, Valentina M. Supper, Mark B. Leick, Filippo Birocchi, Andrew J. Yee, Angelina Petrichenko, John Everett, Frederic D. Bushman, Hossein Sadrzadeh, Otto Rapalino, Daniel Chiu, Isabel Arrillaga-Romany, Marcela V. Maus, Matthew J. Frigault, Kathleen M. E. Gallagher; Chemotherapy-induced reversal of ciltacabtagene autoleucel–associated movement and neurocognitive toxicity. Blood 2023; 142 (14): 1248–1252. doi: https://doi.org/10.1182/blood.2023021429
Download citation file:
My Account
Sign In
October 5 2023
Advertisement intended for health care professionals
Cited By
Advertisement intended for health care professionals
This feature is available to Subscribers Only
Sign In or Create an Account Close Modal